-

NYSE American to Commence Delisting Proceedings Against Mallinckrodt plc (MNK)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Ordinary Shares of Mallinckrodt plc (the “Company”) — ticker symbol MNK — from NYSE American. Trading in the Company’s Ordinary Shares will be suspended immediately.

NYSE Regulation has determined that the Company is no longer suitable for listing and will commence delisting proceedings pursuant to Section 1003(c)(iii) of the NYSE American Company Guide in light of the disclosure on August 28, 2023 that the Company and certain of its subsidiaries today initiated voluntary prepackaged Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. NYSE Regulation noted that the Company’s Restructuring Support Agreement, entered into on August 23, 2023, provides for the cancellation of the Company’s Ordinary Shares for no consideration.

The Company has a right to a review of staff’s determination to delist the Ordinary Shares by a Committee of the Board of Directors of the Exchange. The NYSE American will apply to the Securities and Exchange Commission to delist the Company’s Ordinary Shares upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Investor Relations
Daniel J. Speciale
Global Corporate Controller & Chief Investor Relations Officer
314-654-3638
daniel.speciale@mnk.com

Derek Belz
Vice President, Investor Relations
314-654-3950
derek.belz@mnk.com

Media
Michael Freitag / Aaron Palash / Aura Reinhard / Catherine Simon
Joele Frank, Wilkinson Brimmer Katcher
+1-212-355-4449

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Investor Relations
Daniel J. Speciale
Global Corporate Controller & Chief Investor Relations Officer
314-654-3638
daniel.speciale@mnk.com

Derek Belz
Vice President, Investor Relations
314-654-3950
derek.belz@mnk.com

Media
Michael Freitag / Aaron Palash / Aura Reinhard / Catherine Simon
Joele Frank, Wilkinson Brimmer Katcher
+1-212-355-4449

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE Group Consolidated Short Interest Report

NEW YORK--(BUSINESS WIRE)--NYSE today reported short interest as of the close of business on the settlement date of December 15, 2025. SETTLEMENT DATE EXCHANGE TOTAL CURRENT SHORT INTEREST TOTAL PREVIOUS SHORT INTEREST (Revised) NUMBER of SECURITIES with a SHORT POSITION NUMBER of SECURITIES with a POSITION >= 5,000 SHARES 12/15/2025 NYSE 16,401,052,680 16,170,141,102 2,876 2,555 12/15/2025 NYSE ARCA 2,248,888,701 2,169,649,765 2,519 1,703 12/15/2025 NYSE AMERICAN 818,416,336 772,363,508 303...

NYSE to Commence Delisting Proceedings with Respect to Warrants of UWM Holdings Corporation (UWMC WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol UWMC WS — each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 with an expiration date of January 21, 2026 of UWM Holdings Corporation (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Tr...

NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol RBOT WS — thirty (30) whole warrants are exercisable to purchase one share of Class A common stock of Vicarious Surgical Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s Class A common stock — tick...
Back to Newsroom